Abstract
Because of a recent U.S. Supreme Court decision, one of the legal maneuvers major pharmaceutical manufacturers have been using to extend exclusivity for brand-name drugs could be more diffi cult to use in the future. If so, generic alternatives may come to market more quickly and prices for prescriptions may drop. Or maybe not, depending on what happens from here, Laura Carpenter, BSPharm, JD, LLM, of Carpenter Law Firm PC in Phoenix, told Pharmacy Today.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
